Skip to main content
Dx & Vx Co., Ltd. logo

Dx & Vx Co., Ltd. — Investor Relations & Filings

Ticker · 180400 ISIN · KR7180400004 KO Manufacturing
Open in API
Filings indexed 474 across all filing types
Latest filing 2023-05-26 M&A Activity
Country KR South Korea
Listing KO 180400

About Dx & Vx Co., Ltd.

https://www.dxvx.com/

Dx & Vx Co., Ltd. is a bio-healthcare company specializing in diagnostics and vaccine development. Its diagnostics division offers molecular diagnostic solutions, genomics and bioinformatics services, and customized companion diagnostics (CDx), leveraging an AI-based genome analysis platform. The company's therapeutic pipeline is centered on an innovative mRNA vaccine platform designed for long-term storage at room temperature. Key development areas include vaccines for infectious diseases, immuno-therapeutic cancer vaccines, oral treatments for obesity, and therapies for eye conditions. Additionally, Dx & Vx provides contract development, manufacturing, and sales organization (CDMO/CSO) services and commercializes microbiome-based products and health supplements.

Recent filings

Filing Released Lang Actions
[기재정정]주요사항보고서(타법인주식및출자증권양수결정)
M&A Activity Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) filed with the Korea Exchange (KRX) regarding the acquisition of shares in another company (타법인 주식 및 출자증권 양수결정). It details a correction (정정신고) to the previously announced acquisition date. This type of regulatory filing, which details specific corporate transactions and material events, falls under the 'Regulatory Filings' category as it is a formal disclosure required by the Financial Services Commission/Korea Exchange.
2023-05-26 Korean
대표이사변경
Board/Management Information Classification · 100% confidence The document is a formal announcement regarding a change in the company's CEO (representative director). It details the outgoing director, the incoming director, the reason for the change, and the effective date. This falls directly under the definition of Board/Management Information (MANG).
2023-05-16 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. This type of filing is a standard regulatory requirement for directors and major shareholders to disclose their personal share transactions (insider trading). Based on the provided definitions, this falls under 'Director's Dealing' (DIRS).
2023-05-16 Korean
분기보고서 (2023.03)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for the company 'DXVX' (디엑스앤브이엑스) covering the period from January 1, 2023, to March 31, 2023. It contains detailed financial and operational information, including business overviews, product descriptions, raw material status, production facilities, and sales performance. This aligns with the definition of an Interim/Quarterly Report (IR) as it provides substantive financial data and analysis for a period shorter than a full fiscal year. Q1 2023
2023-05-15 Korean
[기재정정]타법인주식및출자증권취득결정
M&A Activity Classification · 100% confidence The document is a regulatory filing from a Korean company (DXVX) regarding the acquisition of shares in another company (Avixgen). It is explicitly labeled as a 'Correction Report' (정정신고) for a previous disclosure regarding the 'Decision to Acquire Shares and Securities of Other Corporations'. This type of filing is a standard regulatory disclosure for material corporate events, specifically M&A-related activity, and fits best under the 'Regulatory Filings' category as it is a formal disclosure of a business transaction.
2023-05-09 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. This type of filing is a mandatory disclosure of insider trading or changes in share ownership by company directors or major shareholders. According to the provided definitions, this corresponds to 'Director's Dealing' (DIRS).
2023-04-21 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.